Controlled Substance Monitoring and Drugs of Abuse Testing
JH · Effective Oct 1, 2015
30 active Medicare policies list F11.21, and 2 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 20, 2024
JM · Effective Oct 20, 2024
JJ · Effective Oct 20, 2024
JM · Effective Oct 20, 2024
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
2 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of F11.21 |
|---|---|---|
| Stereotactic Cingulotomy and Capsulotomy | May 5, 2023 | Covered |
| Policy | Effective | Status of F11.21 |
|---|---|---|
| Buprenorphine (Brixadi & Sublocade) | Oct 1, 2026 | Covered |
J9 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J15 · Effective Oct 5, 2015
JL · Effective Oct 1, 2024
JL · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
JL · Effective Oct 1, 2025
J9 · Effective Jan 1, 2025
J6 · Effective Oct 1, 2024
National · Effective Mar 26, 2026
National · Effective Mar 26, 2026
J5 · Effective Jan 1, 2026
J9 · Effective Oct 1, 2025
National · Effective Apr 16, 2026
J6 · Effective Oct 1, 2024